SELANK/SEMAX Blend 5mg/5mg

The SELANK/SEMAX Blend 5mg/5mg is a high-purity, research-grade peptide combination containing 5mg of Selank and 5mg of Semax per vial, designed exclusively for laboratory and scientific research. This lyophilized powder blend, intended for reconstitution, combines two synthetic heptapeptides known for their nootropic, neuroprotective, and anxiolytic properties. Developed for research into cognitive enhancement, stress resilience, and neuroprotection, this blend offers a unique opportunity to explore the synergistic effects of Selank and Semax in controlled settings. It is not intended for human or animal consumption, pharmaceutical use, or as a dietary supplement.

• Composition:
  • Selank: 5mg (Thr-Lys-Pro-Arg-Pro-Gly-Pro)
  • Semax: 5mg (Met-Glu-His-Phe-Pro-Gly-Pro)
• Form: Lyophilized (freeze-dried) powder in a sterile, vacuum-sealed glass vial
• Purity: ≥98%, verified by High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry
• Molecular Weight:
  • Selank: ~751.9 g/mol
  • Semax: ~813.9 g/mol
• Molecular Formula:
  • Selank: C₃₃H₅₇N₁₁O₉
  • Semax: C₃₇H₅₁N₉O₁₀S
• Appearance: White to off-white crystalline powder
• Solubility: Soluble in bacteriostatic water or sterile saline for reconstitution
• Packaging: 10mg total peptide content (5mg Selank + 5mg Semax) in a 2mL or 3mL sterile glass vial with a tamper-evident seal
• Storage Conditions:
  • Lyophilized Form: Store at 2-8°C (refrigerator) in a dark, dry environment, away from direct light, heat, or moisture. Stable for up to 2 years.
  • Reconstituted Form: Store at 2-8°C, use within 45 days, and protect from light. Do not freeze after reconstitution to avoid peptide degradation.
• Shelf Life:
  • Unopened: 24 months when stored properly
  • Reconstituted: Up to 45 days under refrigerated conditions
• Intended Use: Exclusively for in vitro laboratory research or in vivo animal studies by qualified researchers. Not for human or animal consumption, therapeutic use, or household purposes.

Selank is a synthetic heptapeptide, an analog of the endogenous immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg), extended with a Pro-Gly-Pro sequence to enhance stability against enzymatic degradation. Developed by the Institute of Molecular Genetics, Russian Academy of Sciences, Selank is noted for its anxiolytic, nootropic, and immunomodulatory effects without the sedative or dependency risks associated with traditional anxiolytics like benzodiazepines.

• Mechanism of Action:
  • Modulates GABAergic neurotransmission by influencing GABA receptor affinity and expression.
  • Increases brain-derived neurotrophic factor (BDNF) levels in the hippocampus, supporting neurogenesis and synaptic plasticity.
  • Enhances serotonin metabolism, contributing to mood stabilization and emotional resilience.
  • Inhibits enkephalin-degrading enzymes, potentially increasing endogenous opioid peptide activity.
  • Modulates interleukin-6 (IL-6) and T helper cell cytokine expression, supporting immune function under stress.
• Potential Research Applications:
  • Anxiolytic Effects: Reduces anxiety-like behaviors in animal models, comparable to low-dose benzodiazepines but without sedation or cognitive impairment.
  • Cognitive Enhancement: Improves memory consolidation, attention, and learning processes in rodent studies.
  • Immunomodulation: Explores effects on immune response under stress, particularly via IL-6 and cytokine modulation.
  • Neuroprotection: Protects against stress-induced neural damage, potentially relevant for PTSD or chronic stress models.
  • Substance Withdrawal: Investigates potential to mitigate withdrawal symptoms in models of opioid or alcohol dependency.
• Research Benefits:
  • Non-sedative anxiolytic properties, ideal for studying anxiety without cognitive suppression.
  • Rapid onset (within minutes in some studies), suitable for acute stress models.
  • Minimal side effects in research settings, with no reported dependency or withdrawal effects.

Semax is a synthetic heptapeptide derived from the adrenocorticotropic hormone (ACTH) fragment (4-10), stabilized with a Pro-Gly-Pro sequence. Also developed by the Institute of Molecular Genetics, Semax is widely studied for its neuroprotective, nootropic, and cognitive-enhancing properties, particularly in Russia, where it has been explored for clinical applications.

• Mechanism of Action:
  • Upregulates BDNF and tropomyosin receptor kinase B (TrkB) expression in the hippocampus, promoting neurogenesis and neuroprotection.
  • Enhances serotonergic and dopaminergic neurotransmission, contributing to mood and cognitive effects.
  • Acts as an antagonist or partial agonist at melanocortin receptors (MC4 and MC5), potentially influencing stress and appetite regulation.
  • Inhibits enkephalin-degrading enzymes, enhancing endogenous peptide activity.
  • Increases acetylcholine activity, supporting attention and memory processes.
• Potential Research Applications:
  • Cognitive Enhancement: Improves attention, short-term memory, and learning in healthy and cognitively impaired animal models.
  • Neuroprotection: Protects neurons from ischemic, hypoxic, or oxidative stress damage, relevant for stroke, traumatic brain injury (TBI), or neurodegenerative disease models (e.g., Alzheimer’s, Parkinson’s).
  • Anxiolytic and Antidepressant Effects: Reduces anxiety and depression-like behaviors in rats via serotonin and dopamine modulation.
  • Stroke and TBI Recovery: Supports neural repair and functional recovery post-injury by increasing BDNF and NGF (nerve growth factor) levels.
  • Neurodegenerative Diseases: Explores potential in models of Parkinson’s, Alzheimer’s, or optic nerve atrophy.
• Research Benefits:
  • Enhances cognitive resilience under stress, fatigue, or high-demand conditions.
  • Supports research into neurorestorative mechanisms, particularly post-ischemic or traumatic injury.
  • Well-tolerated in research models, with minimal side effects at standard doses.

The SELANK/SEMAX 5mg/5mg blend combines Selank’s anxiolytic and immunomodulatory properties with Semax’s neuroprotective and cognitive-enhancing effects, potentially offering synergistic benefits for research into:

• Cognitive Optimization: Enhancing memory, focus, and learning under stress or cognitive demand.
• Emotional and Stress Resilience: Reducing anxiety and depression-like behaviors while maintaining mental clarity and focus.
• Neuroprotection and Repair: Protecting neural tissue and promoting recovery in models of brain injury, ischemia, or neurodegeneration.
• Neuro-Immune Interactions: Investigating combined effects on stress-induced immune dysregulation and neural function.
• Complex Neurological Models: Exploring interactions between anxiety, cognition, and neuroprotection in multifaceted conditions like PTSD, ADHD, or substance withdrawal.

• Reconstitution:
  • Use 1-2 mL of bacteriostatic water (0.9% benzyl alcohol) or sterile saline per vial.
  • Inject solvent slowly along the vial wall using a sterile syringe to avoid foaming.
  • Gently swirl (do not shake) until fully dissolved.
  • Transfer to a sterile amber glass vial or nasal spray bottle for research applications.
• Administration Methods:
  • Subcutaneous Injection:
    • Reconstitute to a concentration of 2.5mg/mL per peptide (e.g., 2mL solvent for 5mg/5mg vial).
    • Administer using a sterile insulin syringe (e.g., 0.3mL or 0.5mL) in animal models.
    • Typical research doses: 300-900 mcg/day for Semax; 200-750 mcg/day for Selank, split into 1-2 administrations.
  • Intranasal Delivery:
    • Reconstitute to 1.25mg/mL per peptide (e.g., 4mL solvent for 5mg/5mg vial).
    • Use a sterile nasal spray bottle delivering ~100-200 μL per spray (125-250 mcg per peptide per spray).
    • Typical research protocol: 1-3 sprays per nostril (200-900 mcg per peptide) once or twice daily.
• Dosing Considerations:
  • Dosing varies by research model and objective. Consult peer-reviewed literature for precise protocols.
  • Example protocols: Semax (10-50 mcg/kg intranasally in rats); Selank (100-300 mcg/kg intranasally or subcutaneously).
  • Cycle durations: Typically 10-14 days in research, with breaks to assess long-term effects.
• Post-Reconstitution Storage:
  • Store at 2-8°C in a sterile, light-protected container.
  • Use within 45 days to ensure stability.
  • Discard if solution appears cloudy or contains particulate matter.

• Purity Assurance:
  • Each batch undergoes rigorous testing via HPLC and Mass Spectrometry to confirm ≥98% purity.
  • Meets U.S. Pharmacopeia (USP) standards for research-grade peptides.
  • Free from endotoxins and microbial contamination, verified by limulus amebocyte lysate (LAL) testing.
• Manufacturing:
  • Produced in a GMP-compliant facility under strict quality control.
  • Sterile filtration and aseptic filling ensure product integrity.
• Safety Precautions:
  • For laboratory research only; not approved for human or animal consumption by the FDA or other regulatory bodies.
  • Avoid use in research models that are pregnant, nursing, or under 18 years of age.
  • Use caution when combining with other anxiolytic, nootropic, or psychotropic compounds in research settings.
  • Handle with sterile gloves and equipment to prevent contamination.

• Potential Side Effects:
  • Selank: Generally well-tolerated; rare reports of mild injection site irritation or nasal discomfort with improper intranasal formulations.
  • Semax: May cause mild sedation or headache-like responses at high doses in some models; nasal irritation possible with frequent intranasal use.
  • Blend: No significant synergistic side effects reported, but researchers should monitor for unexpected interactions in combined administration.
• Contraindications:
  • Avoid in models with hypersensitivity to peptide components.
  • Use caution in models with severe hepatic or renal impairment, as metabolism and excretion pathways are not fully characterized.

The SELANK/SEMAX 5mg/5mg blend is a versatile tool for exploring a wide range of neurological, psychological, and immunological phenomena:

• Neuroscience:
  • Cognitive enhancement in healthy and impaired models (e.g., memory, attention, learning).
  • Neuroprotection in models of stroke, TBI, ischemia, or neurodegenerative diseases (Alzheimer’s, Parkinson’s, optic nerve atrophy).
  • Synaptic plasticity and BDNF/TrkB signaling pathways.
• Psychiatry:
  • Anxiolytic and antidepressant effects in models of anxiety, depression, PTSD, or ADHD.
  • Stress response modulation, particularly under chronic or acute stress conditions.
  • Substance withdrawal (e.g., opioids, alcohol) and behavioral addiction models.
• Immunology:
  • Selank’s effects on IL-6, T helper cells, and immune modulation under stress.
  • Neuro-immune interactions in models of psychosomatic disorders.
• Neurorestoration:
  • Neural repair and functional recovery post-stroke or TBI.
  • Neurogenesis and neuroplasticity in aging or neurodegenerative models.
• Pharmacology:
  • Peptide stability, bioavailability, and pharmacokinetics in various administration routes (subcutaneous, intranasal).
  • Synergistic effects of peptide combinations on neurotransmitter systems (GABA, serotonin, dopamine).

• Regulatory Status: Not approved for human use by the FDA, EMA, or other regulatory authorities. Restricted to laboratory research and animal studies.
• Compliance: Researchers must adhere to local, national, and institutional regulations governing peptide handling, storage, and use.
• Export/Import: Verify compliance with international regulations for shipping and handling of research peptides.
• Labeling: Product is labeled “For Research Use Only” to ensure proper use by qualified professionals.

• High Purity and Quality: ≥98% purity, GMP-compliant manufacturing, and rigorous quality control ensure reliable research outcomes.
• Synergistic Formulation: Combines Selank’s anxiolytic and immunomodulatory effects with Semax’s neuroprotective and cognitive-enhancing properties for comprehensive research potential.
• Versatile Administration: Suitable for subcutaneous or intranasal delivery, accommodating diverse research protocols.
• Extensive Research Support: Backed by decades of studies from Russian and international research, with applications in neurology, psychiatry, and immunology.
• Stable and Convenient: Lyophilized form ensures long shelf life and ease of storage; reconstitution flexibility supports varied administration methods.

This product is intended for research purposes only. It is not a drug, supplement, or cosmetic. Researchers are responsible for ensuring compliance with all applicable regulations and ethical guidelines. Misuse or unauthorized use may result in legal or safety consequences.